The CVS Health Corporation line shows up 183 times in the congressional disclosure record between 2013 and 2026, filed by 53 members: 92 purchases against 90 sales. On balance the chamber has been net buyers, and the purchases sit up 57.1% against the latest close.
*Purchases only, weighted by the midpoint of each disclosed dollar band and marked to the latest close. Filings report a range, never a share count, so this follows the stock rather than anyone's position size.
Members ranked by how their reported CVS purchases have moved since, over roughly the last three years, weighted by disclosed band midpoint and marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2015-12-22 | Debbie Dingell | BUY | $15K–$50K | $98.27 | $92.53 2026-10-26 | -5.8% |
| 2015-11-19 | K. Michael Conaway | SELL | $1K–$15K | $92.49 | $92.53 2026-10-26 | -0.0% exit |
| 2015-11-11 | Lois Frankel | SELL | $1K–$15K | $94.85 | $92.53 2026-10-26 | +2.5% exit |
| 2015-11-04 | Lois Frankel | SELL | $1K–$15K | $99.57 | $92.53 2026-10-26 | +7.1% exit |
| 2015-10-30 | James B. Renacci | BUY | $1K–$15K | $98.78 | $92.53 2026-10-26 | -6.3% |
| 2015-10-26 | James B. Renacci | BUY | $1K–$15K | $103.47 | $92.53 2026-10-26 | -10.6% |
| 2015-10-26 | Robert J. Wittman | SELL | $1K–$15K | $103.47 | $92.53 2026-10-26 | +10.6% exit |
| 2015-09-15 | Robert J. Wittman | BUY | $1K–$15K | $101.60 | $92.53 2026-10-26 | -8.9% |
| 2015-08-31 | Kenny Marchant | SELL | $1K–$15K | $102.40 | $92.53 2026-10-26 | +9.6% exit |
| 2015-08-25 | Kenny Marchant | BUY | $1K–$15K | $100.00 | $92.53 2026-10-26 | -7.5% |
| 2015-08-20 | James B. Renacci | BUY | $1K–$15K | $106.02 | $92.53 2026-10-26 | -12.7% |
| 2015-08-11 | John B. Larson | BUY | $1K–$15K | $108.08 | $92.53 2026-10-26 | -14.4% |
| 2015-07-15 | Kenny Marchant | BUY | $1K–$15K | $109.90 | $92.53 2026-10-26 | -15.8% |
| 2015-05-29 | James B. Renacci | BUY | $1K–$15K | $102.38 | $92.53 2026-10-26 | -9.6% |
| 2015-04-06 | Michael T. McCaul | SELL | $100K–$250K | $103.43 | $92.53 2026-10-26 | +10.5% exit |
| 2015-04-06 | Michael T. McCaul | SELL | $100K–$250K | $103.43 | $92.53 2026-10-26 | +10.5% exit |
| 2015-03-25 | Michael T. McCaul | SELL | $50K–$100K | $102.73 | $92.53 2026-10-26 | +9.9% exit |
| 2015-03-25 | Michael T. McCaul | SELL | $15K–$50K | $102.73 | $92.53 2026-10-26 | +9.9% exit |
| 2015-03-24 | Michael T. McCaul | BUY | $100K–$250K | $104.49 | $92.53 2026-10-26 | -11.4% |
| 2015-03-24 | Michael T. McCaul | BUY | $100K–$250K | $104.49 | $92.53 2026-10-26 | -11.4% |
| 2015-02-15 | Kenny Marchant | BUY | $1K–$15K | $102.63 | $92.53 2026-10-26 | -9.8% |
| 2015-02-10 | Alan S. Lowenthal | BUY | $15K–$50K | $101.68 | $92.53 2026-10-26 | -9.0% |
| 2015-01-13 | Susan M Collins | BUY | $1K–$15K | $97.24 | $92.53 2026-10-26 | -4.8% |
| 2014-11-07 | K. Michael Conaway | SELL | $1K–$15K | $88.38 | $92.53 2026-10-26 | -4.7% exit |
| 2014-09-18 | Sheldon Whitehouse | BUY | $1K–$15K | $81.18 | $92.53 2026-10-26 | +14.0% |
| 2014-04-29 | Sheldon Whitehouse | BUY | $1K–$15K | $73.47 | $92.53 2026-10-26 | +25.9% |
| 2014-04-29 | Sheldon Whitehouse | BUY | $1K–$15K | $73.47 | $92.53 2026-10-26 | +25.9% |
| 2014-04-17 | Sheldon Whitehouse | SELL | $1K–$15K | $73.74 | $92.53 2026-10-26 | -25.5% exit |
| 2014-04-17 | Sheldon Whitehouse | SELL | $1K–$15K | $73.74 | $92.53 2026-10-26 | -25.5% exit |
| 2014-01-30 | Susan M Collins | BUY | $1K–$15K | $67.65 | $92.53 2026-10-26 | +36.8% |
| 2013-06-25 | JOHN F REED | SELL | $1K–$15K | $56.62 | $92.53 2026-10-26 | -63.4% exit |
| 2013-06-25 | JOHN F REED | BUY | $1K–$15K | $56.62 | $92.53 2026-10-26 | +63.4% |
| 2013-05-14 | SUSAN M COLLINS | SELL | $1K–$15K | $60.07 | $92.53 2026-10-26 | -54.0% exit |
Buys are marked to the latest close and treated as open. A sell tagged rt closes an earlier disclosed buy in the same name. exit shows how the stock moved after the member sold.
53 members of the U.S. House and Senate have disclosed CVS Health Corporation transactions under the STOCK Act — 92 purchases and 90 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a CVS purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed CVS buys are up 57.1% versus the latest close of $96.74. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded CVS and how it performed.